Göksel Çinier1, Ahmet İlker Tekkeşin1, Tuğba Yanar Çelik2, Özlem Mercan2, Halil İbrahim Tanboğa3, Muhammed Burak Günay1, Ceyhan Türkkan1, Mert İlker Hayıroğlu4, Bryce Alexander4, Ahmet Taha Alper1, Adrian Baranchuk5. 1. Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Research and Training Hospital, Department of Cardiology, Kadikoy, Istanbul, Turkey. 2. HaydarpasaNumuneEgitimveArastırmaHastanesi, Department of Neurology, Kadikoy, Istanbul, Turkey. 3. Hisar Intercontinental Hospital, Department of Cardiology, Umraniye, Istanbul, Turkey. 4. Haydarpaşa Sultan Abdulhamit Han EğitimveAraştırmaHastanesi, Department of Cardiology, Kadikoy, Istanbul, Turkey. 5. Kingston General Hospital, Department of Cardiology, Queen's University, ON, Canada.
Abstract
INTRODUCTION: Previous studies demonstrated that interatrial block (IAB) is associated with atrial fibrillation (AF) in different clinical scenarios. The aim of our study was to determine whether IAB could predict silent ischemic brain lesions (sIBL), detected by magnetic resonance imaging (MRI). METHODS: Patients presented to a neurology clinic with transient ischemic attack (TIA) symptoms and underwent brain MRI were included to the study. sIBL were defined as lesions without corresponding clinical symptoms regarding lesion localization evaluated by two neurologists. A 12-lead surface ECG was obtained from each patient. IAB was defined as P-wave duration > 120 ms with (advanced IAB) or without (partial IAB) biphasic morphology in the inferior leads. RESULTS: sIBL was detected in 61 (49.6%) patients. Patients with sIBL were older (P<0.001), had more left ventricular hypertrophy (LVH) (P=0.02) and higher CHA2DS2-VASc score compared to those without (P<0.001). P-wave duration was significantly longer in patients with sIBL (124 [110.5 - 129] msvs 107 [102 - 116.3] ms) (P<0.001). IAB was diagnosed in 36 patients (59%) with sIBL (+) and in 11 patients (18%) with sIBL (-); p<0.001. Multivariate logistic regression analysis identified age [Odds ratio (OR), 1.061; 95% confidence interval (CI), 1.012 - 1.113; p=0.014], CHA2DS2-VASc score (OR, 1.758; 95% CI, 1.045 - 2.956; p=0.034), LVH (OR, 3.062; 95% CI, 1.161 - 8.076; p=0.024) and IAB (including both partial and advanced) (OR, 5.959; 95% CI, 2.269 - 15.653; p<0.001) as independent predictors of sIBL. CONCLUSION: IAB is a strong predictor of sIBL and can be easily diagnosed by performing surface 12-lead ECG.
INTRODUCTION: Previous studies demonstrated that interatrial block (IAB) is associated with atrial fibrillation (AF) in different clinical scenarios. The aim of our study was to determine whether IAB could predict silent ischemic brain lesions (sIBL), detected by magnetic resonance imaging (MRI). METHODS: Patients presented to a neurology clinic with transient ischemic attack (TIA) symptoms and underwent brain MRI were included to the study. sIBL were defined as lesions without corresponding clinical symptoms regarding lesion localization evaluated by two neurologists. A 12-lead surface ECG was obtained from each patient. IAB was defined as P-wave duration > 120 ms with (advanced IAB) or without (partial IAB) biphasic morphology in the inferior leads. RESULTS: sIBL was detected in 61 (49.6%) patients. Patients with sIBL were older (P<0.001), had more left ventricular hypertrophy (LVH) (P=0.02) and higher CHA2DS2-VASc score compared to those without (P<0.001). P-wave duration was significantly longer in patients with sIBL (124 [110.5 - 129] msvs 107 [102 - 116.3] ms) (P<0.001). IAB was diagnosed in 36 patients (59%) with sIBL (+) and in 11 patients (18%) with sIBL (-); p<0.001. Multivariate logistic regression analysis identified age [Odds ratio (OR), 1.061; 95% confidence interval (CI), 1.012 - 1.113; p=0.014], CHA2DS2-VASc score (OR, 1.758; 95% CI, 1.045 - 2.956; p=0.034), LVH (OR, 3.062; 95% CI, 1.161 - 8.076; p=0.024) and IAB (including both partial and advanced) (OR, 5.959; 95% CI, 2.269 - 15.653; p<0.001) as independent predictors of sIBL. CONCLUSION: IAB is a strong predictor of sIBL and can be easily diagnosed by performing surface 12-lead ECG.
Authors: Philipp Kahlert; Stephan C Knipp; Marc Schlamann; Matthias Thielmann; Fadi Al-Rashid; Marcel Weber; Uwe Johansson; Daniel Wendt; Heinz G Jakob; Michael Forsting; Stefan Sack; Raimund Erbel; Holger Eggebrecht Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: Fiorenzo Gaita; Laura Corsinovi; Matteo Anselmino; Cristina Raimondo; Martina Pianelli; Elisabetta Toso; Laura Bergamasco; Carlo Boffano; Maria Consuelo Valentini; Federico Cesarani; Marco Scaglione Journal: J Am Coll Cardiol Date: 2013-07-10 Impact factor: 24.094
Authors: Adrian Baranchuk; Brendan Parfrey; Leonard Lim; Florence Morriello; Christopher S Simpson; Wilma M Hopman; Damian P Redfearn; Michael Fitzpatrick Journal: Cardiol J Date: 2011 Impact factor: 2.737
Authors: Taya V Glotzer; Emile G Daoud; D George Wyse; Daniel E Singer; Michael D Ezekowitz; Christopher Hilker; Clayton Miller; Dongfeng Qi; Paul D Ziegler Journal: Circ Arrhythm Electrophysiol Date: 2009-08-04
Authors: Sarah E Vermeer; Monika Hollander; Ewoud J van Dijk; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: Stroke Date: 2003-04-10 Impact factor: 7.914
Authors: Antonio Bayés de Luna; Pyotr Platonov; Francisco G Cosio; Iwona Cygankiewicz; Carlos Pastore; Rafa Baranowski; Antoni Bayés-Genis; Josep Guindo; Xavier Viñolas; Javier Garcia-Niebla; Raimundo Barbosa; Shlomo Stern; David Spodick Journal: J Electrocardiol Date: 2012-09 Impact factor: 1.438